Physician profile
Deepika Abbadi
NPI 1205191210
$1,817.47
in general payments reported to CMS, 2019-2025
15 companies · $305 in 2025
The $305 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $478 · 2020: $206 · 2021: $196 · 2022: $142 · 2023: $172 · 2024: $319 · 2025: $305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $795.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $795.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $711.80 | 2023-2025 | Watchman Access System |
| Astellas Pharma US INC | $405.93 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $258.11 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $105.16 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $102.50 | 2020-2025 | Lifevest |
| Abbott Laboratories | $48.05 | 2019-2021 | |
| Amgen INC. | $37.79 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $30.54 | 2023-2025 | Camzyos |
| Pfizer INC. | $28.34 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $27.69 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $16.24 | 2019 | |
| Chiesi USA, INC. | $16.23 | 2021 | |
| Lundbeck LLC | $15.84 | 2019 | |
| Gilead Sciences, INC. | $12.90 | 2019 | |
| Travere Therapeutics, INC. | $0.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepika Abbadi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.